Dangerous Drugs

Dangerous Drug Lawyers in Los Angeles

Product Liability Trial Lawyers With More Than $600 Million Recovered

A dangerous drug claim can arise when a medication contains a manufacturing error, contamination, inadequate warning, undisclosed interaction, or defect that causes serious harm despite being used as directed. Symptoms may develop quickly or appear months or years later, making prescription records, medical history, packaging, and the timing of health changes important to the investigation.

Pharmaceutical testing can’t identify every risk before a drug reaches a larger patient population. Problems may also arise later through manufacturing mistakes, contamination, misleading marketing, or evidence that a manufacturer failed to communicate known dangers. If you suspect a medication caused an injury, don’t stop, restart, or change it without first speaking with your doctor or pharmacist.

Defective medications can cause lasting side effects whether the danger stems from an active ingredient or contamination during manufacturing.

If you or a loved one was seriously injured by a dangerous or recalled drug, call (866) 884-1717 or contact our Los Angeles drug injury lawyers for a consultation.

Relentlessly Pursuing the Best Possible Outcome

We've Recovered Hundreds of Millions for Our Clients

$30m Product Liability Verdict
$24m Wrongful Death Settlement
$14m Medical Device Settlement
$13.5m Personal Injury
$12m Child Wrongful Death
$11m Personal Injury

SEE MORE SUCCESSES

Types of Drug Defect Claims

A defective drug claim is a legal action brought by someone harmed by a pharmaceutical product alleged to be unsafe because of its design, manufacture, labeling, or marketing.

If you were prescribed a pharmaceutical drug that caused injury, you may have a defective products claim. The evidence may support more than one theory, but using a medication and developing a known side effect doesn’t automatically prove that the product was legally defective.

Defectively Manufactured Pharmaceutical Drugs: This type of claim addresses a drug that departed from its intended formula or specifications. An error may occur while the medication is being made, bottled, shipped, stored, or labeled. Contamination, an incorrect ingredient, the wrong dosage, or a packaging mix-up may support a pharmaceutical manufacturing defect investigation.
Dangerous Design or Side Effects: Even if the drug was manufactured as intended, its design or risk profile may cause serious injury. These cases require close analysis of the applicable law, medical evidence, known risks, available alternatives, and what the manufacturer knew at relevant points in time.
Improperly Marketed Pharmaceutical Drugs: Marketing includes a drug’s warnings, instructions, contraindications, and promoted uses. A failure-to-warn claim may involve inaccurate or incomplete risk information given to prescribing professionals or patients. Advice provided by a doctor, pharmacist, or other medical provider may raise separate issues that aren’t the same as a product liability claim against a manufacturer.

Individuals who have suffered harm due to a defective drug may seek compensation for medical expenses, lost wages, pain and suffering, and other damages through a defective drug claim. Recoverable product-liability damages depend on the evidence, applicable law, and the losses connected to the injury.

Our Los Angeles dangerous drug lawyers can evaluate which legal theories fit the available evidence and whether the medication’s design, manufacture, warnings, or promotion may support a claim.

Injuries Associated With Dangerous Drugs

Victims of defective or recalled drugs may face acute injuries, progressive illnesses, permanent impairment, ongoing monitoring, additional treatment, lost income, or caregiving needs. Conditions discussed in drug injury allegations include:

Cancer: Claims involving Zantac have alleged increased risks of cancers affecting the bladder, stomach, kidneys, and other organs. The medical and legal viability of an individual claim depends on current scientific evidence and case-specific exposure details.
Bleeding Disorders: Anticoagulants such as Xarelto and Pradaxa have been associated with serious bleeding risks. A review must account for the prescribing reason, dosage, other medications, warnings provided, and the patient’s medical history.
Organ Damage: Some medications have been associated with kidney or liver injuries that may require continued treatment, monitoring, or transplantation.
Gastrointestinal Injuries: Lawsuits involving drugs such as Ozempic have alleged gastroparesis, chronic nausea, persistent vomiting, and bowel obstruction. A drug name or reported symptom alone doesn’t establish causation.
Vision Loss: Elmiron litigation has involved allegations of pigmentary maculopathy and permanent retinal damage following long-term use.
Birth Defects and Heart Attacks: Certain drug injury inquiries involve developmental injuries in unborn children or cardiac events in adults.

Long-term consequences of dangerous drugs may include chronic illness, permanent disability, and the need for ongoing care and surveillance. Medical causation typically requires review of the prescribing history, dosage, duration, prior conditions, other medications, diagnostic testing, and the timing of symptoms.

What to Do After a Suspected Drug Injury

If you believe a prescription or over-the-counter drug caused serious harm, protect your health first and preserve the information that may be needed for a medical or legal review:

Continue or Adjust Medication Only Under Medical Supervision: Don’t stop, restart, or change medications without first talking to your doctor or pharmacist. The safest response can depend on the medication, dosage, condition being treated, and current recall instructions.
Retain Unused Medication and Packaging: Save pills, bottles, boxes, inserts, lot numbers, expiration information, and receipts. Don’t return or discard the product before obtaining guidance about preserving it.
Keep All Medical Records and Prescriptions: Retain prescription records, pharmacy records, treatment notes, diagnostic results, and communications about warnings or recalls.
Document All Symptoms and Health Changes: Use a journal or calendar to note symptoms, dates, medical visits, missed work, and changes in daily activities.
Contact a Los Angeles Defective Drug Attorney Early: Our product liability lawyers can investigate regulatory records, identify potentially responsible parties, evaluate medical causation issues, and assess the filing period that may apply.

Prompt action can help preserve physical evidence and records before medication is discarded, packaging is lost, or documentation becomes more difficult to obtain.

California Deadlines for Drug Injury Claims

California personal injury claims generally have a two-year filing period, but a dangerous drug lawsuit doesn’t always run from a simple or obvious date. The calculation may depend on when the injury occurred, when it was discovered or reasonably should have been discovered, the defendants and legal theories involved, and whether a tolling rule applies.

Delayed symptoms, later diagnoses, newly issued warnings, and other case-specific facts can complicate the California statute of limitations. A general deadline statement isn’t a substitute for legal advice based on the medication, medical history, and potential defendants in a particular case.

Why Dangerous Drug Cases Require Product Liability Investigation

A side-effect report is only one part of a pharmaceutical injury inquiry. The investigation may also examine the drug’s labeling history, manufacturing records, recall notices, adverse-event evidence, regulatory communications, marketing materials, prescribing context, and medical causation.

Depending on the facts, relevant evidence may concern a manufacturer, distributor, retailer, marketer, testing entity, or another participant in the chain of distribution. FDA approval, regulatory compliance, a warning, or a recall may be significant, but none of those facts automatically resolves whether a defect caused an individual patient’s injury.

For a free consultation, reach out by calling (866) 884-1717 or sending us a message.

Proving Liability in a Defective Drug Claim

In California, strict liability laws may play a role in defective drug claims. Strict liability is a legal doctrine that can hold parties responsible for injuries caused by defective products without requiring proof of ordinary negligence. Its application to prescription medications depends on the alleged defect, the legal theory, and the facts, so a plaintiff can’t assume that every serious side effect creates strict liability.

Important elements considered in California defective drug claims include:

Defective Product or Inadequate Warning: The plaintiff may need to show a manufacturing defect, a legally actionable design problem, or inadequate warnings or instructions. Strict liability, negligence, warranty, and other theories can involve different elements and defenses.
Causation: The plaintiff must demonstrate a causal connection between the defect or warning issue and the injuries suffered. Medical causation may be contested when the patient had prior conditions, used multiple medications, or developed symptoms after a significant delay.
Injuries: The plaintiff must have suffered legally recognized harm from using the defective drug. This can include physical injuries, emotional distress, medical expenses, lost income, and other legally recognized damages.
Product’s Condition When Sold: The condition of the medication when it left a defendant’s control can be important. Lot records, packaging, storage history, pharmacy documentation, and testing may help determine whether the drug differed from its intended specifications.

FDA approval doesn’t automatically defeat a claim, and a recall doesn&rsquot automatically establish one. Regulatory compliance, drug labeling, prescribing-provider warnings, product use, causation disputes, and California law may all affect the analysis.

Holding Pharmaceutical Companies Accountable for Dangerous Drugs

A serious adverse drug event doesn’t by itself prove that a pharmaceutical company violated the law. Liability must be supported by evidence concerning the product, warnings, manufacturing process, promotion, medical connection, and conduct of a legally responsible party.

At Shoop | A Professional Law Corporation, our Los Angeles defective drug attorneys investigate whether a manufacturer knew or should have known about a significant risk, accurately communicated that risk, and produced the medication according to its intended specifications. We also examine whether the evidence supports a legally actionable defect or failure to warn rather than relying on the drug name or injury alone.

Who May Be Liable for a Defective Drug?

Aside from pharmaceutical companies, other parties may need to be investigated in a dangerous drug claim. Responsibility depends on each party’s role, the available evidence, and the legal theory permitted under the applicable law.

Potentially relevant parties may include:

Distributors and Retailers: Wholesalers, pharmacies, and retailers may be investigated when evidence concerns storage, labeling, distribution, recall procedures, or the condition of a medication within the supply chain.
Healthcare Professionals: A prescribing or administering provider’s conduct may raise separate medical malpractice questions involving informed consent, contraindications, or patient monitoring. Those issues shouldn’t be conflated with a product liability claim against a drug manufacturer.
Testing Laboratories: A laboratory may be relevant if its testing, reporting, or quality-control work bears on the alleged defect or undisclosed risk.
Marketing and Advertising Agencies: Entities involved in promoting a drug may be investigated if the evidence concerns misleading statements, unapproved promotion, or material risks omitted from marketing communications.
Other Supply-Chain Participants: Depending on the facts, entities involved in manufacturing, labeling, packaging, importing, or distributing a medication may possess important evidence or face a viable claim.

Regulatory agencies such as the FDA issue approvals, safety communications, warnings, and recall information, but they aren’t ordinarily treated as product defendants in a defective drug lawsuit. Their records may nevertheless provide important evidence about drug labeling, manufacturing issues, adverse events, and the timing of safety actions.

Trial Resources for Complex Pharmaceutical Cases

Our firm focuses on product liability and catastrophic injury trial work. We carefully evaluate potential claims, preserve critical evidence, consult qualified medical and scientific professionals, and prepare matters for litigation when the evidence supports moving forward.

David R. Shoop previously litigated multi-million-dollar matters for major corporations and insurers before representing injured consumers. That background informs how we assess defenses involving regulatory compliance, alternative medical causes, prescribing decisions, warnings, product use, and the claimed absence of a defect.

Our firm has recovered more than $600 million in verdicts and settlements, including nine-figure product liability recoveries and numerous multi-million-dollar results. David R. Shoop also secured a $30 million product liability verdict in Los Angeles County. Past results don’t predict the outcome of a pharmaceutical injury claim, but they reflect the resources and trial preparation we bring to complex product litigation.

Continue Reading Read Less

Our Impressive Track Record We Win...A Lot!

In the last 14 years, Shoop & team's impressive track record includes hundreds of Product Liability cases resulting in verdicts or settlements exceeding $1 million. For a Product Liability team with an exemplary track record, clients choose Shoop.

SEE OUR WINS

FDA Drug Recalls & Recall Classifications

A drug may be recalled because of contamination, manufacturing errors, incorrect strength, packaging or labeling problems, or newly identified evidence of a health hazard. A safety communication, label update, market withdrawal, and formal recall aren’t interchangeable, so patients should confirm the action that applies to their medication.

Recall Process & Current Safety Information

A historical analysis by Physicians for a National Health Program reported that around 27% of drugs are given new warnings or taken off the market within the first 16 years after introduction. That analysis shouldn’t be treated as a current recall list or proof that a particular drug is defective.

A historical report noted that voluntary drug recalls are made at the discretion of the manufacturer, but the authority and process involved can depend on the product and current federal law. The FDA may request action, oversee a recall, publish enforcement information, and issue instructions to patients and healthcare professionals.

Independent testing can also identify potential concerns. For example, reports from third-party labs contributed to scrutiny of ranitidine products. Patients should rely on current FDA notices, manufacturer instructions, and advice from a treating clinician or pharmacist rather than assuming that an older report describes a medication’s present status.

Recall Classifications & Patient Guidance

Not all recalls carry the same relative health hazard. The FDA assigns a class after evaluating the potential consequences:

Class I: There is a reasonable probability that use of or exposure to the product can cause serious adverse health consequences or death.
Class II: Use of or exposure to the product can cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote.
Class III: Use of or exposure to the product isn’t likely to cause adverse health consequences.

A market withdrawal is different from a Class I, II, or III recall. It can involve a minor issue or another circumstance that doesn’t meet the criteria for an FDA recall. Neither a recall classification nor a withdrawal determines whether a particular patient has a viable lawsuit.

If your medication is affected by a recall:

Compare the medication name, manufacturer, dosage, lot number, expiration information, and product description with the official notice.
Preserve the bottle, packaging, inserts, receipts, and remaining medication unless current safety instructions require another action.
Speak with your doctor or pharmacist before stopping, restarting, replacing, or changing the dosage of a medication.
Follow current instructions from the FDA, manufacturer, pharmacy, or treating clinician.

Medications Named in Dangerous Drug Claims

Drug-specific information must distinguish between a confirmed recall, an updated warning, allegations in litigation, and established medical evidence.

Existing dangerous drug inquiries have involved products and medications such as:

Essure
Tadalafil
Taxotere
Truvada
Valsartan
Zantac

A medication’s appearance on this list doesn’t establish that it was defective, that it caused a particular injury, or that a current claim remains available. The product used, dates of use, dosage, diagnosis, warnings in effect at the time, and current litigation status all require individual verification.

Examples of Drug Warnings, Withdrawals & Litigation

Several widely used medications have been associated with recalls, labeling changes, safety communications, or product liability allegations. Their regulatory and litigation status can change, so each matter should be checked against current authoritative records:

Zantac (Ranitidine): In 2020, the FDA requested the removal of all ranitidine products from the market after determining that levels of N-nitrosodimethylamine could increase under certain storage conditions. Cancer claims have since involved drug-specific scientific evidence and differing court rulings.
Ozempic and Wegovy (Semaglutide): These medications haven’t been subject to a general FDA recall based on the gastrointestinal allegations discussed in product liability lawsuits. Claims have alleged gastroparesis, persistent vomiting, bowel obstruction, and inadequate warnings, but those allegations don’t establish causation in an individual case.
Elmiron: Drug labeling includes information about retinal pigmentary changes reported with long-term use. Litigation has alleged pigmentary maculopathy, progressive vision damage, and failure to provide adequate warnings.
Xarelto and Pradaxa: These anticoagulants carry significant bleeding risks and have been the subject of product liability litigation. Evaluation of a claim requires the warnings in effect during use, the patient’s medical history, other medications, and evidence connecting the drug to the bleeding event.

Some pharmaceutical cases proceed through multidistrict litigation, a federal procedure that coordinates similar lawsuits for pretrial matters while preserving each plaintiff’s individual claim. Other cases may proceed separately in state or federal court. Participation in coordinated litigation doesn’t predict compensation or eliminate the need to prove defect, causation, injury, and damages.

For a full list of current recalled drugs, visit the FDA’s website, or call our drug recall attorneys in Los Angeles to discuss the medication, your injury, and the evidence relevant to a potential case.

Request a Dangerous Drug Case Review

If you or a loved one was harmed by a dangerous drug, the Los Angeles defective drug attorneys at Shoop | A Professional Law Corporation can review the medication, injury, medical history, warnings, and available product evidence. Our firm has recovered more than $600 million in verdicts and settlements for clients, including significant product liability recoveries.

We offer complimentary consultations and contingency representation, so you won’t owe an attorney fee unless we recover compensation for you. Every matter is evaluated on its own facts, and past results don’t predict a future outcome.

Call (866) 884-1717 or contact us today to schedule a confidential consultation.

Continue Reading Read Less

Contact Us for Your Free Consultation

First Name
Please enter your first name.
Last Name
Please enter your last name.
Phone
Please enter your phone number.

This isn't a valid phone number.
Email
Please enter your email address.

This isn't a valid email address.
Are you a new client?
Please make a selection.
How can we help you?
Please enter a message.
By submitting, you agree to receive text messages from Shoop | A Professional Law Corporation at the number provided, including those related to your inquiry, follow-ups, and review requests, via automated technology. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency may vary. Reply STOP to cancel or HELP for assistance. Acceptable Use Policy
DISCLAIMER* The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Time-sensitive information should not be sent through this form.